ZA962089B - Use of notric oxide donors and/or substrates or nitric oxide inhibitors for regulating cervical dilatation and extensibility - Google Patents

Use of notric oxide donors and/or substrates or nitric oxide inhibitors for regulating cervical dilatation and extensibility

Info

Publication number
ZA962089B
ZA962089B ZA962089A ZA962089A ZA962089B ZA 962089 B ZA962089 B ZA 962089B ZA 962089 A ZA962089 A ZA 962089A ZA 962089 A ZA962089 A ZA 962089A ZA 962089 B ZA962089 B ZA 962089B
Authority
ZA
South Africa
Prior art keywords
nitric oxide
extensibility
substrates
notric
inhibitors
Prior art date
Application number
ZA962089A
Other languages
English (en)
Inventor
Kristof Chwalisz
Robert E Garfield
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of ZA962089B publication Critical patent/ZA962089B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/223—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of alpha-aminoacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
ZA962089A 1995-03-14 1996-03-14 Use of notric oxide donors and/or substrates or nitric oxide inhibitors for regulating cervical dilatation and extensibility ZA962089B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95250059 1995-03-14

Publications (1)

Publication Number Publication Date
ZA962089B true ZA962089B (en) 1997-08-27

Family

ID=8221039

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA962089A ZA962089B (en) 1995-03-14 1996-03-14 Use of notric oxide donors and/or substrates or nitric oxide inhibitors for regulating cervical dilatation and extensibility

Country Status (26)

Country Link
US (1) US6333350B1 (no)
EP (1) EP0814785B1 (no)
JP (1) JP4579349B2 (no)
KR (2) KR100434239B1 (no)
CN (1) CN1151781C (no)
AT (1) ATE377417T1 (no)
AU (1) AU713172B2 (no)
CA (1) CA2214779A1 (no)
CZ (1) CZ292395B6 (no)
DE (1) DE69637313T2 (no)
ES (1) ES2297838T3 (no)
HU (1) HUP9800826A3 (no)
ID (1) ID20742A (no)
IL (1) IL117496A (no)
IS (1) IS4555A (no)
MX (1) MX9707007A (no)
MY (1) MY116500A (no)
NO (1) NO318598B1 (no)
NZ (1) NZ305169A (no)
PL (1) PL183461B1 (no)
RU (1) RU2199346C2 (no)
SK (1) SK124197A3 (no)
TW (1) TW421594B (no)
UA (1) UA57703C2 (no)
WO (1) WO1996028145A1 (no)
ZA (1) ZA962089B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4579349B2 (ja) 1995-03-14 2010-11-10 バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト 子宮頸の拡大及び拡張度を制御するための酸化窒素供与体及び／又は基質又は酸化窒素インヒビター
WO1997031631A1 (en) * 1996-02-27 1997-09-04 Rpms Technology Limited Cox-2 selective inhibitors for managing labour and uterine contractions
US6232434B1 (en) 1996-08-02 2001-05-15 Duke University Medical Center Polymers for delivering nitric oxide in vivo
DE19809845A1 (de) 1998-03-03 1999-09-09 Jenapharm Gmbh S-substituierte 11beta-Benzaldoxim-estra-4,9-dien-kohlensäurethiolester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
ITMI20002117A1 (it) * 2000-09-29 2002-03-29 Ibsa Inst Biochimique Sa Uso di sodio nitroprussiato in ostetricia e ginecologia
WO2005023189A2 (en) * 2003-09-03 2005-03-17 Pharmacia Corporation Method of cox-2 selective inhibitor and nitric oxide-donating agent
WO2006089561A1 (en) * 2005-02-23 2006-08-31 Abbas Abdelsalam Ghazi Pharmaceutical compositions containing organic acids useful for softening and ripening uterine cervix.
US8828981B2 (en) 2007-02-06 2014-09-09 George Creasy Progesterone for the treatment or prevention of spontaneous preterm birth
CN102283827A (zh) * 2008-10-16 2011-12-21 四川维信医药科技有限责任公司 单硝酸异山梨酯的新用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5508045A (en) 1992-10-09 1996-04-16 The Regents Of The University Of California Method and agents for control and management of labor during pregnancy
HUT74465A (en) * 1993-11-16 1996-12-30 Schering Ag Pharmaceutical composition which useable for treatment of uterine contractility disorders containing a nitric oxide synthase substrate and/or donor, or a nitric oxide inhibitor
US5550369A (en) 1994-02-28 1996-08-27 Electro-Pro, Inc. Triangulation position detection method and apparatus
JP4579349B2 (ja) 1995-03-14 2010-11-10 バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト 子宮頸の拡大及び拡張度を制御するための酸化窒素供与体及び／又は基質又は酸化窒素インヒビター

Also Published As

Publication number Publication date
PL322252A1 (en) 1998-01-19
KR100434239B1 (ko) 2004-06-09
IL117496A0 (en) 1997-03-18
TW421594B (en) 2001-02-11
SK124197A3 (en) 1998-06-03
EP0814785A1 (en) 1998-01-07
IS4555A (is) 1997-09-05
NO974204L (no) 1997-11-13
MX9707007A (es) 1998-06-30
ID20742A (id) 1999-02-25
PL183461B1 (pl) 2002-06-28
IL117496A (en) 2002-12-01
CN1151781C (zh) 2004-06-02
CZ285197A3 (cs) 1998-03-18
ES2297838T3 (es) 2008-05-01
ATE377417T1 (de) 2007-11-15
RU2199346C2 (ru) 2003-02-27
CZ292395B6 (cs) 2003-09-17
JPH11502200A (ja) 1999-02-23
MY116500A (en) 2004-02-28
DE69637313D1 (de) 2007-12-20
AU713172B2 (en) 1999-11-25
UA57703C2 (uk) 2003-07-15
WO1996028145A1 (en) 1996-09-19
JP4579349B2 (ja) 2010-11-10
HUP9800826A3 (en) 1998-08-28
KR19980703060A (ko) 1998-09-05
NZ305169A (en) 1999-10-28
NO318598B1 (no) 2005-04-18
DE69637313T2 (de) 2008-09-04
AU5311796A (en) 1996-10-02
KR20040004515A (ko) 2004-01-13
KR100434238B1 (ko) 2004-07-16
EP0814785B1 (en) 2007-11-07
HUP9800826A1 (hu) 1998-07-28
US6333350B1 (en) 2001-12-25
NO974204D0 (no) 1997-09-12
CA2214779A1 (en) 1996-09-19
CN1182366A (zh) 1998-05-20

Similar Documents

Publication Publication Date Title
TW272940B (en) /
MY141415A (en) Therapeutic combination containing interferon
ZA933023B (en) The use of inhibitors of plasminogen activators for the treatment of inflammations and wounds.
CA2222303A1 (fr) Utilisation d'au moins un inhibiteur de no-synthase dans le traitement des peaux sensibles
AU5157096A (en) Fabric article with extension indicator
NO307027B1 (no) Anvendelse av riluzol ved behandling av neurologiske lesjoner relatert til traumatiske skader
AU5635396A (en) Alpha-substituted pyrimidine-thioalkyl and alkylether compounds
ZA931318B (en) Method of treatment
IL117496A0 (en) Nitric oxide donors and/or substrates and nitric oxide inhibitors for regulating cervical dilatation
NO960775L (no) Anvendelse av kinoksaliner i kombinasjon med proteaseinhibitorer som legemiddel for behandling av AIDS og/eller HIV-infeksjoner
TW325997B (en) Pharmaceutical composition for preventing and treating retinal diseases
GR3036241T3 (en) METHOD OF TREATMENT OF CHRONIC PROSTATITIS WITH 17-g(b)-N-MONOSUBSTITUTED-CARBAMOYL-4-AZA-5-g(a)-ANDROST-1-EN-3-ONES.
AU2968792A (en) Method of preventing reocclusion of arteries
TW291439B (no)
NO962503L (no) Anvendelse av penoksyfyllin ved behandling av multippel sklerose
ES8700940A1 (es) Procedimiento de obtencion de composiciones para el trata- miento de infecciones por rinovirus
GB9310049D0 (en) Growth factor effects
UA29236A (uk) Спосіб лікування пізніх гестозів
IL123382A0 (en) Preparation for the prophylaxis and/or treatment of wool and hair loss
UA40027A (uk) Спосіб лікування фето-плацентарної недостатності
UA10000A (uk) Спосіб лікування гострої недостатності тканинного дихання